Hepatotoxicity After Immune Checkpoint Inhibitor Therapy in Melanoma: Natural Progression and Management

Objective:To report the clinical features, treatment, and outcomes of patients with immune checkpoint inhibitor-induced hepatotoxicity.Patients and Methods:In this retrospective observational study, we identified patients with metastatic malignant melanoma seen in consultation and/or treated between